Trials / Sponsors / InnoPharmax Inc.
InnoPharmax Inc.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer Biliary Tract Cancer (BTC) | Phase 3 | 2026-05-01 |
| Recruiting | Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Trac Biliary Tract Cancer | Phase 2 / Phase 3 | 2022-03-29 |
| Completed | Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subj Gastrointestinal Cancer, Biliary Tract Cancer | Phase 1 / Phase 2 | 2018-08-06 |
| Completed | Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and M Advanced Solid Malignancies, Malignant Lymphomas | Phase 1 | 2013-04-01 |
| Completed | An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumo Malignant Tumors | EARLY_Phase 1 | 2012-08-01 |